The Weight Loss Revolution: How Far Will We Go? Eli Lilly's announcement of promising results for its experimental injectable drug, retatrutide, has sent shockwaves through the medical community and beyond.
This new medication targets three hormones related to weight loss, a significant departure from current treatments that focus on one or two.
A New Era in Obesity Treatment The results of Lilly's study are remarkable: participants who received retatrutide injections lost up to 28% of their body weight over 1. 5 years.